Endovia Health Sciences, Inc.
New York Stock Exchange ArcaTotal Valuation
Endovia Health Sciences, Inc. carries a market capitalization of 1.02M, placing it among publicly traded companies globally. Its enterprise value stands at 6.14M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.02M |
| Enterprise Value | 6.14M |
Share Statistics
Endovia Health Sciences, Inc. currently has 4.04M shares outstanding.
| Shares Outstanding | 4.04M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Enterprise Valuation
| EV / Sales | 9.39 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
Financial Position
Endovia Health Sciences, Inc. maintains a current ratio of 0.05, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -40.55, indicating conservative leverage, while an interest coverage ratio of -5.19 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.05 |
| Quick Ratio | 0.02 |
| Debt / Equity | -40.55 |
| Debt / EBITDA | -0.47 |
| Interest Coverage | -5.19 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -148.26 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | -0.90 |
Stock Price Statistics
Endovia Health Sciences, Inc.'s stock has declined approximately -51.7116% over the past 52 weeks. The 50-day moving average sits at 0.31, while the 200-day moving average is 1.38.
| Beta (5Y) | N/A |
| 52-Week Price Change | -51.7116% |
| 50-Day Moving Average | 0.31 |
| 200-Day Moving Average | 1.38 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Endovia Health Sciences, Inc. generated -360,982.00 in revenue and converted that into -17.28M in net income, yielding earnings per share of -10.32. EBITDA reached -13.50M, while operating income came in at -13.51M.
| Revenue | -360,982.00 |
| Gross Profit | 49,189.00 |
| Operating Income | -13.51M |
| Pretax Income | -16.35M |
| Net Income | -17.28M |
| EBITDA | -13.50M |
| EBIT | -13.51M |
| Earnings Per Share (EPS) | -10.32 |
Balance Sheet
Endovia Health Sciences, Inc. holds 242,702.00 in cash and equivalents against 6.39M in total debt, resulting in a net debt position of 6.14M. Total book value stands at -15.75M, with working capital of -15.92M providing operational flexibility.
| Cash & Cash Equivalents | 242,702.00 |
| Total Debt | 6.39M |
| Net Debt | 6.14M |
| Equity (Book Value) | -15.75M |
| Book Value Per Share | -3.90 |
| Working Capital | -15.92M |
Cash Flow
Endovia Health Sciences, Inc. produced -5.45M in operating cash flow over the past twelve months.
| Operating Cash Flow | -5.45M |
| Capital Expenditures | N/A |
| Free Cash Flow | -5.45M |
| FCF Per Share | -3.44 |
Margins
Endovia Health Sciences, Inc. operates with a gross margin of -13.63, reflecting its pricing power and cost economics. The operating margin of 3,741.86 and net profit margin of 4,787.65 provide insight into operational efficiency.
| Gross Margin | -13.63 |
| Operating Margin | 3,741.86 |
| Pretax Margin | 4,529.48 |
| Profit Margin | 4,787.65 |
| EBITDA Margin | 3,739.93 |
Dividends & Yields
The company's payout ratio of 2.25 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | 2.25 |
| Shareholder Yield | N/A |
| FCF Yield | N/A |
Scores
Endovia Health Sciences, Inc. posts an Altman Z-Score of -302.51, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -302.51 |